Latest Breaking News On - Amarin vascepa - Page 1 : comparemela.com

Ensuring Innovation Act Changes Eligibility for New Chemical Exclusivity

Law aims to encourage competition in the pharmaceutical industry, making it easier for generics to enter market.

United statesDistrict of columbiaJosephr bidenAmarin vascepaUs district courtDepartment of healthDrug administrationAmarin pharma incCommonwealth fundHuman servicesPresident josephEnsuring innovation actFederal foodDrug price competitionPatent term restoration actHatch waxman act

Amarin: The Question Of A Turnaround (NASDAQ:AMRN)

After the generic infringement debacle, Amarin transitioned from a growth stock to a turnaround play. See it can turn around with pressure from Sarissa Capital?

United statesNew jerseyGalina zhigalovaAlex dennerAmarin vascepaWarren buffettVascepa amarinCarl icahnAmarin corporationIntegrated biosci investingSarissa capitalBridgewater new jerseyDublin irelandSarrisa capitalChief investment officerLeading sarissa

Duane Morris LLP - District Court of Delaware Rules for Generic Pharma s Use of Skinny Label, but Permits Induced Infringement Suit to Proceed Against Insurer

Duane Morris LLP - District Court of Delaware Rules for Generic Pharma s Use of Skinny Label, but Permits Induced Infringement Suit to Proceed Against Insurer
duanemorris.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from duanemorris.com Daily Mail and Mail on Sunday newspapers.

United statesAmarin pharmaAmarin vascepaHikma pharmsHealth netDistrict courtTeva pharmaceuticals united states incPharmaceuticals united statesFederal circuit

Two Pharma And Biotech Cases To Watch In 2022 - Intellectual Property

As we enter the second month of 2022, the old saying, "If at first you don't succeed, try, try again" and the famous line, "I'm not dead," from Monty Python and the Holy Grail, come to mind to describe two issues.

United statesAmarin vascepaTeva pharmIdenix pharmsHikma pharmsHealth netDrug administrationSupreme courtWyeth cordis corpAmgen incAmarin pharma incAbbott labsMonty pythonHoly grailFederal circuitAmarin pharma

Inducement Suit Proceeds Against Insurance Company For Encouraging Use Of Generic Drug - Intellectual Property

Generic drug makers often use "skinny labels" to carve out approved indications that are covered by an innovator's patents, and thus to avoid liability for inducing infringement.

Amarin vascepaHealth netAbbreviated new drug applicationFederal circuitInducement suit proceeds against insurance company for encouraging use of generic drugLife sciencesFood and drugs lawIntellectual property